Next |
home / stock / pbla / pbla message board
Subject | By | Source | When |
---|---|---|---|
$PBLA in the news following $7 price target: | JDCruz | investorshub | 04/28/2023 5:36:13 PM |
$PBLA Price gaining last trade up | TheFinalCD | investorshub | 04/27/2023 6:54:50 PM |
Long and strong lets hope im right | molee | investorshub | 04/27/2023 5:40:48 PM |
Oh , I can relate , as I | molee | investorshub | 04/27/2023 5:19:45 AM |
Can you imagine how the shareholders feel? IMHO | subslover | investorshub | 04/26/2023 7:06:14 PM |
$PBLA just had a 1:40 stock split Jan. | molee | investorshub | 04/26/2023 7:02:14 PM |
Here is the problem and it will be | subslover | investorshub | 04/26/2023 6:51:21 PM |
I believe something is brewing. It's going up | SriMaharaj | investorshub | 04/26/2023 5:59:50 PM |
$PBLA .49 AGAIN | TheFinalCD | investorshub | 04/26/2023 4:13:49 PM |
$PBLA: No PR's, etc., that I can find either. | Invest-in-America | investorshub | 04/26/2023 1:35:20 PM |
.78 https://www.benzinga.com/news/23/04/32005454/hc-wainwright-co-initiates-coverage-on-panbela-ther | TheFinalCD | investorshub | 04/26/2023 1:32:22 PM |
HC Wainwright initiated coverage with buy recommendation $7 | James salmon | investorshub | 04/26/2023 1:30:23 PM |
nope just tech move | TheFinalCD | investorshub | 04/26/2023 1:19:41 PM |
No News? | subslover | investorshub | 04/26/2023 12:53:24 PM |
$PBLA .73 | TheFinalCD | investorshub | 04/26/2023 12:43:32 PM |
Damn | Awl416 | investorshub | 04/26/2023 12:39:17 PM |
short squeeze signal | molee | investorshub | 04/26/2023 11:57:28 AM |
$PBLA .49 | TheFinalCD | investorshub | 04/26/2023 11:27:21 AM |
$PBLA news out | molee | investorshub | 04/26/2023 8:27:20 AM |
$PBLA Looks pretty positive | Backstabbed | investorshub | 04/25/2023 11:29:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
Panbela Therapeutics Inc Com Website:
DSMB Recommends Continuation without Modification for Third Time Safety Review Included 395 Patients Interim Survival Analysis Still Expected Early 2025 given Lower-Than-Expected Event Rate Low Event Rate Suggests Potential for Prolonged Survival Rapid Enrollment P...
MINNEAPOLIS, June 10, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (OTCQB: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announces an oral presentation at the Digestive Disease Week (DDW) conference,...
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...